#bipolardisordercare — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #bipolardisordercare, aggregated by home.social.
-
DATE: May 20, 2026 at 03:53PM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
Christoph Correll, MD, presented efficacy and real-world data on olanzapine-samidorphan for schizophrenia and bipolar disorder at #APAAM26. He found that it keeps olanzapine efficacy yet limits weight gain, improves negative symptoms, and cuts ER visits. https://t.co/KtkDV2kd6m
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #OlanzapineSamidorphan #SchizophreniaTreatment #BipolarDisorderCare #MentalHealthInnovation #APAAM26
-
DATE: May 20, 2026 at 03:53PM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
Christoph Correll, MD, presented efficacy and real-world data on olanzapine-samidorphan for schizophrenia and bipolar disorder at #APAAM26. He found that it keeps olanzapine efficacy yet limits weight gain, improves negative symptoms, and cuts ER visits. https://t.co/KtkDV2kd6m
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #OlanzapineSamidorphan #SchizophreniaTreatment #BipolarDisorderCare #MentalHealthInnovation #APAAM26
-
DATE: May 20, 2026 at 03:53PM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
Christoph Correll, MD, presented efficacy and real-world data on olanzapine-samidorphan for schizophrenia and bipolar disorder at #APAAM26. He found that it keeps olanzapine efficacy yet limits weight gain, improves negative symptoms, and cuts ER visits. https://t.co/KtkDV2kd6m
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #OlanzapineSamidorphan #SchizophreniaTreatment #BipolarDisorderCare #MentalHealthInnovation #APAAM26
-
DATE: May 19, 2026 at 10:45AM
SOURCE: PSYCHIATRIC TIMESDirect article link at end of text block below.
Patients with preexisting severe mental illness, including schizophrenia and bipolar disorder, who subsequently develop cancer face significant disparities in cancer screening and access to care, shared Michelle Riba, MD, MS. #APAAM26
https://t.co/wlnjxcqKU2Here are any URLs found in the article text:
Articles can be found by scrolling down the page at Articles can be found at https://www.psychiatrictimes.com/news".
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #psychotherapist #MentalHealthAndCancer #CancerCareAccess #SchizophreniaAwareness #BipolarDisorderCare #HealthDisparities